{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:52:25Z","timestamp":1773661945732,"version":"3.50.1"},"reference-count":11,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,4,7]],"date-time":"2004-04-07T00:00:00Z","timestamp":1081296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>A 19\u2010year\u2010old woman with severe HLA B27 spondyloarthropathy whose disease was controlled on cyclosporin, methotrexate and prednisolone had human papillomavirus infection and developed cervical dysplasia and a large number of cutaneous and vulval warts. These were not responsive to cryotherapy, salicylic acid or cimetidine, so she was treated with topical imiquimod 5% cream. Two weeks after starting this treatment she had a significant flare of her spondyloarthropathy. She was so ill that she stopped using the imiquimod cream. She had full resolution of her warts after 3\u00a0weeks' treatment with imiquimod cream, but her spondyloarthropathy took more than 3\u00a0months to improve, despite significant augmentation of her immunosuppression. This case highlights the potential risk of using imiquimod cream (an immunostimulant) in a patient who has a condition requiring immunosuppression, such as autoimmune disease or an organ transplant.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2004.00060.x","type":"journal-article","created":{"date-parts":[[2004,4,7]],"date-time":"2004-04-07T07:32:19Z","timestamp":1081323139000},"page":"123-124","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Imiquimod: Potential risk of an immunostimulant"],"prefix":"10.1111","volume":"45","author":[{"given":"Elizabeth","family":"Benson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,7]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958020-00017"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(01)00095-0"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(98)00068-X"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2002.00017.x"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni758"},{"key":"e_1_2_4_7_2","first-page":"210","article-title":"Treatment of genital warts with an immune response modifier (imiquimod)","volume":"38","author":"Boutner KR","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912030-00011"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(01)00095-0"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00174.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.9.2059"},{"key":"e_1_2_4_12_2","first-page":"3528","article-title":"Inhibition of murine tumor growth by an interferon\u2010inducing imidazoquinolinamine","volume":"52","author":"Sidky YA","year":"1992","journal-title":"Cancer Res."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2004.00060.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2004.00060.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:29:09Z","timestamp":1697192949000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2004.00060.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,7]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1440-0960.2004.00060.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2004.00060.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,7]]},"assertion":[{"value":"2004-04-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}